|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61P 35/00 | (2006.01) |
| G01N 33/57484 | (2013.01) | ||
| C12Q 1/6886 | (2018.01) | ||
| G01N2800/52 | (2013.01) | ||
| G01N 33/53 | (2006.01) | ||
| C12Q 1/6886 | (2013.01) | ||
| C12Q2600/106 | (2013.01) | ||
| C12Q2600/158 | (2013.01) | ||
| A61P 35/00 | (2018.01) |
| (11) | Patento numeris | 3383496 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 16871597.7 |
| Europos patento paraiškos padavimo data | 2016-12-02 | |
| (97) | Europos patento paraiškos paskelbimo data | 2018-10-10 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2022-05-25 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2016/064679 |
| Data | 2016-12-02 |
| (87) | Numeris | WO 2017/096201 |
| Data | 2017-06-08 |
| (30) | Numeris | Data | Šalis |
| 201562262242 P | 2015-12-02 | US |
| (72) |
MILES, Linde , US
POIRIER, John , US
RUDIN, Charles , US
|
| (73) |
Memorial Sloan-Kettering Cancer Center ,
Office of Technology Development
1275 York Avenue
Box 524, New York, NY 10065,
US
|
| (54) | SENECA VALLEY VIRUS (SVV) CELLULAR RECEPTOR TARGETED ONCOTHERAPY |
| SENECA VALLEY VIRUS (SVV) CELLULAR RECEPTOR TARGETED ONCOTHERAPY |